Niloofar Rahmani

Array ( [id] => 6945294 [patent_doc_number] => 20050197343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases' [patent_app_type] => utility [patent_app_number] => 10/519487 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12791 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197343.pdf [firstpage_image] =>[orig_patent_app_number] => 10519487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866102 [patent_doc_number] => 20060100233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them' [patent_app_type] => utility [patent_app_number] => 10/522254 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16969 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100233.pdf [firstpage_image] =>[orig_patent_app_number] => 10522254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924660 [patent_doc_number] => 20060241177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Novel compounds, pharmaceutical compositions containing same, and methods of use for same' [patent_app_type] => utility [patent_app_number] => 10/519804 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11738 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241177.pdf [firstpage_image] =>[orig_patent_app_number] => 10519804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070213 [patent_doc_number] => 20050245598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Bafilomycin-like metabolite from a novel micromonospora species' [patent_app_type] => utility [patent_app_number] => 10/517788 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5784 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245598.pdf [firstpage_image] =>[orig_patent_app_number] => 10517788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875424 [patent_doc_number] => 20060167042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Quinuclidine amide derivatives' [patent_app_type] => utility [patent_app_number] => 10/518714 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18111 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167042.pdf [firstpage_image] =>[orig_patent_app_number] => 10518714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808396 [patent_doc_number] => 20060094751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Quinuclidine derivatives and pharmaceutical compositions containing the same' [patent_app_type] => utility [patent_app_number] => 10/518496 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25997 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094751.pdf [firstpage_image] =>[orig_patent_app_number] => 10518496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7389523 [patent_doc_number] => 20040030194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Method for the preparation of 11(12)-pentadecen-15-olides' [patent_app_type] => new [patent_app_number] => 10/463872 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5226 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030194.pdf [firstpage_image] =>[orig_patent_app_number] => 10463872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739048 [patent_doc_number] => 20060009439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Novel physiologically active substances' [patent_app_type] => utility [patent_app_number] => 10/515647 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72812 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009439.pdf [firstpage_image] =>[orig_patent_app_number] => 10515647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978641 [patent_doc_number] => 20050288359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Agents and methods for the treatment of disorders associated with oxidative stress' [patent_app_type] => utility [patent_app_number] => 10/515722 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9289 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288359.pdf [firstpage_image] =>[orig_patent_app_number] => 10515722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912998 [patent_doc_number] => 20050176756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => '3-Substituted quinuclidines and their use' [patent_app_type] => utility [patent_app_number] => 10/512570 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8079 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176756.pdf [firstpage_image] =>[orig_patent_app_number] => 10512570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415395 [patent_doc_number] => 07279580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Imidazo-pyridine derivatives as ligands for GABA receptors' [patent_app_type] => utility [patent_app_number] => 10/512984 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30136 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279580.pdf [firstpage_image] =>[orig_patent_app_number] => 10512984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866046 [patent_doc_number] => 20060100177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Stabilized ascorbic acid derivatives' [patent_app_type] => utility [patent_app_number] => 10/510756 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12936 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100177.pdf [firstpage_image] =>[orig_patent_app_number] => 10510756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913217 [patent_doc_number] => 20050176975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Selective acylation of secondary hydroxyl groups' [patent_app_type] => utility [patent_app_number] => 10/510063 [patent_app_country] => US [patent_app_date] => 2003-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9515 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176975.pdf [firstpage_image] =>[orig_patent_app_number] => 10510063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483881 [patent_doc_number] => 07220872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Conversion of taxane molecules' [patent_app_type] => utility [patent_app_number] => 10/510120 [patent_app_country] => US [patent_app_date] => 2003-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6118 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220872.pdf [firstpage_image] =>[orig_patent_app_number] => 10510120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 586002 [patent_doc_number] => 07442708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => '1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same' [patent_app_type] => utility [patent_app_number] => 10/509919 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20213 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442708.pdf [firstpage_image] =>[orig_patent_app_number] => 10509919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474593 [patent_doc_number] => 20040122083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Antitubulin assembly and cell growth inhibitor denominated \"dioxostatin\"' [patent_app_type] => new [patent_app_number] => 10/275789 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12773 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122083.pdf [firstpage_image] =>[orig_patent_app_number] => 10275789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888307 [patent_doc_number] => 07348339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Imidazopyridine derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/508760 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42349 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348339.pdf [firstpage_image] =>[orig_patent_app_number] => 10508760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105436 [patent_doc_number] => 20050107419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Condensed heterocyclic compounds as calcitonin agonists' [patent_app_type] => utility [patent_app_number] => 10/507006 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47372 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107419.pdf [firstpage_image] =>[orig_patent_app_number] => 10507006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5876156 [patent_doc_number] => 20060167280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Method for purifying simvastatin' [patent_app_type] => utility [patent_app_number] => 10/503769 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2680 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167280.pdf [firstpage_image] =>[orig_patent_app_number] => 10503769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252851 [patent_doc_number] => 07579485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Process for producing lactone' [patent_app_type] => utility [patent_app_number] => 10/502595 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6496 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579485.pdf [firstpage_image] =>[orig_patent_app_number] => 10502595 [rel_patent_id] =>[rel_patent_doc_number] =>)